# Effects of Dihydropyridine Calcium Channel Inhibitors on Respiratory Gas Exchanges in the Intensive Care Unit: a Pharmacovigilance Study in VigiBase® and a Comparison With Urapidil

> **NCT05537194** · — · COMPLETED · sponsor: **University Hospital, Caen** · enrollment: 32000000 (actual)

## Conditions studied

- Hypoxia

## Interventions

- **DRUG:** dihydropyridine calcium channel inhibitors use

## Key facts

- **NCT ID:** NCT05537194
- **Lead sponsor:** University Hospital, Caen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 1963-01-01
- **Primary completion:** 2022-08-14
- **Final completion:** 2022-08-14
- **Target enrollment:** 32000000 (ACTUAL)
- **Last updated:** 2022-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05537194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05537194, "Effects of Dihydropyridine Calcium Channel Inhibitors on Respiratory Gas Exchanges in the Intensive Care Unit: a Pharmacovigilance Study in VigiBase® and a Comparison With Urapidil". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05537194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*